Redmile Group, LLC Insider Trading $FATE FATE THERAPEUTICS INC
Get free email notifications about insider trading for Redmile Group, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Redmile Group, LLC. Redmile Group, LLC is 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in VAPOTHERM INC ($VAPO) and in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in Neoleukin Therapeutics, Inc. ($NLTX) and in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in FATE THERAPEUTICS INC ($FATE) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Atreca, Inc. ($BCEL) and 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Allakos Inc. ($ALLK) and 10% Owner in Stoke Therapeutics, Inc. ($STOK) and Director in Shattuck Labs, Inc. ($STTK) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Gritstone Oncology, Inc. ($GRTS) and 10% Owner in Allovir, Inc. ($ALVR) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in HOOKIPA Pharma Inc. ($HOOK) and 10% Owner in Aprea Therapeutics, Inc. ($APRE) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR).
Redmile Group, LLC in FATE THERAPEUTICS INC
Trading Symbol: FATEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Redmile Group, LLC: Director
Holdings: 12,957,222 shares
Current Value: $36,280,222
Latest Transaction: Jan 12 2021
$FATE Market Capitalization: $95.27M
$FATE Previous Close: $2.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Redmile Group, LLC in FATE THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, ALDR, ALLK, ALVR, FOLD, ANNX, APRE, ARRY, BCEL, BEAM, CABA, FATE, GRTS, HOOK, IGMS, KYMR, NLTX, NRIX, PLRX, RPTX, REPL, STTK, STOK, SYRS, TCRR, VAPO, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | P | 0.00 | 257,310 | 257 | 257,310 | |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Buy | P | 85.50 | 327,485 | 27,999,968 | 12,957,222 | 12.6 M to 13 M (+2.59 %) |
Jun 17 2020 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Buy | P | 28.31 | 1,412,928 | 39,999,992 | 12,629,737 | 11.2 M to 12.6 M (+12.60 %) |
May 05 2020 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | A | 26.59 | 16,000 | 425,440 | 16,000 | |
Sep 17 2019 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Buy | P | 17.50 | 857,143 | 15,000,003 | 11,216,809 | 10.4 M to 11.2 M (+8.27 %) |
Aug 02 2019 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | G | 0.00 | 25,000 | 0 | 0 | |
Aug 02 2019 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | J | 0.00 | 25,000 | 0 | 25,000 | |
Aug 02 2019 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | J | 0.00 | 25,000 | 0 | 2,794,549 | |
May 06 2019 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | A | 17.15 | 16,000 | 274,400 | 16,000 | |
Sep 27 2018 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Buy | P | 13.50 | 3,703,704 | 50,000,004 | 10,359,666 | 6.7 M to 10.4 M (+55.64 %) |
Aug 02 2018 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | A | 8.93 | 24,000 | 214,320 | 24,000 |
Page: 1